Intravesical injection of botulinum toxin A in patients with refractory interstitial cystitis/ painful bladder syndrome - Intravesical injection of botulinum toxin A in patients with refractory interstitial cystitis/ painful bladder syndrome

Department of Urology, Unversity of Tokyo hospital0 sites50 target enrollmentNovember 15, 2010

ConditionsInterstitial cystitis/ Painful bladder syndrome (IC/ PBS)

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Interstitial cystitis/ Painful bladder syndrome (IC/ PBS)
Sponsor: Department of Urology, Unversity of Tokyo hospital
Enrollment: 50
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

November 15, 2010

End Date

March 1, 2013

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Department of Urology, Unversity of Tokyo hospital

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Phase 2

Botulinum toxin A intravesical injections in the treatment of Bladder Pain Syndrome/ Interstitial Cystitis.

NL-OMON31587Vrije Universiteit Medisch Centrum12

Active, Not Recruiting

N/A

Botulinum toxin A intravesical injections in the treatment of Bladder Pain Syndrome/Interstitial CystitisInterstitial Cystitis (IC) is a syndrome characterized by bladder pain associated with urgency, frequency, nocturia, dysuria and sterile urine. The patho-physiology remains largely unclear. No universally, effective, treatment exists. Botulinum toxin-A (BTX-A) inhibits the release of acetylcholine at the presynaptic cholinergic junction resulting in temporally muscle relaxation and bladder desensitisation. We explore the effects of intravesical injections with BTX-A in the treatment of IC.

EUCTR2007-005164-27-NLresearch office urology VUmc12

Active, Not Recruiting

Phase 1

Intravesikal instillation af Botulinum toxin type A til patienter med urge urininkontinens

EUCTR2008-006526-34-DKGynækologisk-obstetrisk afd. G, Glostrup Hospital20

Active, Not Recruiting

N/A

Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) - CP(BTX)PS

EUCTR2007-001602-24-DEDepartment of Urology and Pediatric Urology - Justus-Liebig-University Giessen

Completed

N/A

Subepithelial injection of botulinum toxin A for non-neurogecic overactive bladderon-neurogenic overactive bladder

JPRN-UMIN000001422ational Center for Geriatrics & Gerontology45